PAR · —
Groupe CRIT SA (CEN.PA) Stock
$52.40
+0.38%
PAR: CEN.PA
—
—
Valuation
Financials & Margins
Latest News
Acarix secures approval in UAE for CADScor system
Medical Device Network · Aug 11, 2026
Form 8.3
Business Wire · Aug 11, 2026
Net Asset Value(s)
Business Wire · Aug 11, 2026
Jazz Pharmaceuticals to acquire Actio Biosciences for $820m upfront
Pharmaceutical Technology · Aug 11, 2026
Jefferies Adjusts Price Target on Expedia to $375 From $310, Maintains Buy Rating
MT Newswires · Aug 11, 2026
Valuation & Return Ratios
Peer Comparison
About Groupe CRIT SA
—
over the past 52 weeks the stock has ranged between $49.60 and $67.60, and currently trades 22.5% below its 52-week high.